A randomized comparison of CPX-351 and FLAG-Ida in high-risk myelodysplastic syndrome: A subgroup analysis of UK NCRI AML19.

Mehta P, Skacel T, Faderl S, Murphy R, Park S, Thomas A, Johnson S, Legg A

Open source

DOI
10.1016/j.lrr.2026.100609
Published
2026
Container
Leukemia research reports
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lrr.2026.100609,
  title = {A randomized comparison of CPX-351 and FLAG-Ida in high-risk myelodysplastic syndrome: A subgroup analysis of UK NCRI AML19.},
  author = {Mehta P and Skacel T and Faderl S and Murphy R and Park S and Thomas A and Johnson S and Legg A},
  year = {2026},
  journal = {Leukemia research reports},
  doi = {10.1016/j.lrr.2026.100609},
  url = {https://doi.org/10.1016/j.lrr.2026.100609}
}

RIS

TY  - JOUR
TI  - A randomized comparison of CPX-351 and FLAG-Ida in high-risk myelodysplastic syndrome: A subgroup analysis of UK NCRI AML19.
AU  - Mehta P
AU  - Skacel T
AU  - Faderl S
AU  - Murphy R
AU  - Park S
AU  - Thomas A
AU  - Johnson S
AU  - Legg A
PY  - 2026
JO  - Leukemia research reports
DO  - 10.1016/j.lrr.2026.100609
UR  - https://doi.org/10.1016/j.lrr.2026.100609
ER  - 

APA

P, M., T, S., S, F., R, M., S, P., A, T., S, J., & A, L. (2026). A randomized comparison of CPX-351 and FLAG-Ida in high-risk myelodysplastic syndrome: A subgroup analysis of UK NCRI AML19.. Leukemia research reports. https://doi.org/10.1016/j.lrr.2026.100609

Source records